NYU Langone Medical Centers earns both Stage 7 hospital and ambulatory recognition

HIMSS Analytics has awarded NYU Langone Medical Center’s Tisch Hospital, Rusk Rehabilitation and Hospital for Joint Diseases with its Stage 7 Award, and NYU Langone’s ambulatory practices with its Stage 7 Ambulatory Award.

This is the first hospital enterprise in New York State to receive these prestigious awards.

Stage 7 of the EMR Adoption Model (EMRAM), a measurement of a hospital's implementation and utilization of IT applications, indicates an advanced patient record environment.

“The Stage 7 awards signify the highest and most optimized level of EHR adoption in NYU Langone's hospital setting and across the ambulatory network, which includes leveraging and governing health data and analytics, computer order entry & electronic documentation, paperless registration, and patient engagement,” said Nader Mherabi, senior vice president and vice dean, chief information officer at NYU Langone Medical Center. “The technology both demands and enables precise information sharing between healthcare providers and patients, and is critical to achieving NYU Langone’s commitment to providing world-class medicine.”

During the fourth quarter of 2015, only 4.2 percent of the more than 5,400 U.S. hospitals in the HIMSS Analytics Logic market intelligence received the Stage 7 Award, and only 7.89 percent of the more than 36,000 ambulatory clinics in HIMSS Analytics Logic received the Stage 7 Ambulatory Award.

NYU Langone Medical Center will be recognized at the 2017 Annual HIMSS Conference & Exhibition in Orlando.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”